Eucardia srl, an innovative SME founded in 2013, is focused on developing a revolutionary cardiovascular device called the Heart Damper®. This implantable medical device aims to provide a simpler, less invasive, and more cost-effective solution for patients suffering from advanced systolic heart failure, with the goal of improving their quality and life expectancy while simultaneously reducing healthcare costs. The company, based in Italy, received a notable €71.43K grant investment on 01 December 2018 from the EASME - EU Executive Agency for SMEs. Eucardia's innovative approach and potential impact in the health care industry make it an intriguing prospect for investors seeking opportunities in the medical technology sector. More information can be found on their website with the slogan "Eucardia mette il turbo al cuore malato, senza bisogno di batterie: scopri come su www.eucardia.it".
No recent news or press coverage available for Eucardia srl.